CRISPR New High-Throughput AAV CRISPR Screening Method Could Enable Study of Diverse Tissue Types Swiss scientists who developed AAV-Perturb-seq said the method is "tuneable" and broadly applicable for transcriptional linkage analysis. Broken String Biosciences Closes $15M Series A Financing Round Illumina Ventures and Mérieux Equity Partners led the round for the Cambridge, UK-based therapy-focused gene editing analysis company. Startup CrisprBits Forms Strategic Collaboration With MolBio Diagnostics The Indian firms will partner to accelerate manufacturing and distribution of CRISPR-based point-of-care diagnostics for pathogens and genetic markers. Human Pigmentation Genes Identified With Gene Editing Screen With the help of a CRISPR-based genetic screen, researchers tracked down genes and processes involved in melanin production and pigmentation. Screening Study IDs Functions for Conserved Proteins in 'Unknome' Collection Investigators used RNAi screening and CRISPR editing validation testing in fruit flies to untangle functional contributions for conserved proteins with unknown functions. Jul 28, 2023 Study Explores Role of Prostate Cancer Mutations in 3' Untranslated Regions Jul 27, 2023 Sherlock Bioscience to Launch Free AI-Based Operating System for CRISPR Dx Development Premium Jun 28, 2023 Eukaryotes Have CRISPR-Like Systems That Can Edit Genomes, MIT Teams Report Premium Jun 20, 2023 Human-Specific Features Found With CRISPR Screening on Stem Cells Jun 5, 2023 Bristol Myers Squibb, Medic Life Sciences Collaborate on Tumor Target Discovery Jun 1, 2023 ERS Genomics, Applied Biological Materials Ink Gene Editing Licensing Agreement May 24, 2023 Blood Pressure Genetic Variants Linked to Regulatory Functions, Cardiovascular Pathways May 18, 2023 US Patent Office Invalidates Two Agilent Technologies Patents Covering CRISPR Guide RNAs May 11, 2023 Formerly PerkinElmer, Revvity Discusses Plans, Goals as Dx, Life Science Firm Premium May 4, 2023 UK's Paragraf Acquires Biomolecule Detection Firm Cardea Bio May 1, 2023 CRISPR Delivery Method Offers Gentler Approach to Editing T Cells Premium Apr 28, 2023 Familial Glioma Study Uncovers New Risk Genes Apr 12, 2023 Function Oncology Launches With $28M, Seeks to Transform Precision Cancer Therapy With CRISPR Premium Mar 2, 2023 Avance Biosciences Licenses Gene Editing Off-Target Analysis Method From SeQure Dx Feb 16, 2023 Machine Learning Algorithm Predicts Efficiency of Prime Editing Insertions Feb 10, 2023 Sherlock Biosciences Expects Sense Biodetection Buy to Accelerate Commercialization Plans Premium Feb 1, 2023 Sherlock Biosciences to Acquire Sense Biodetection Jan 31, 2023 CRISPR QC Developing Electronic Platform to Measure Gene Editing Performance Premium Jan 25, 2023 Cardiac-Related Consequences of Alcohol Flushing Genetic Variant Reduced by Drug Jan 10, 2023 CRISPR QC Raises $1.6M in Seed Funding Load More Breaking News Plasmid Transfer Let Cholera Pathogen in Yemen Become Multidrug Resistant, Study Suggests Harbinger Health Raises $140 Million in Series B Financing BioMérieux's BioFire Defense Secures $18.8M US DoD Contract for Infectious Disease Testing Biora Therapeutics Settles Claims of Misleading Genetic Testing Advertisements Genetic Overlap Between Schizophrenia, Cardiovascular Disease Risk Uncovered by GWAS Analysis The Scan Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants. Small Study of Gene Editing to Treat Sickle Cell Disease In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms. Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema. Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.